Gastric cancer: Epidemiology, risk factors and prevention strategies

被引:34
作者
Lei Yang [1 ]
Xiangji Ying [2 ]
Shuo Liu [1 ]
Guoqing Lyu [3 ]
Zekuan Xu [4 ]
Xi Zhang [1 ]
Huichao Li [1 ]
Qingyu Li [1 ]
Ning Wang [1 ]
Jiafu Ji [2 ]
机构
[1] Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control,Peking University Cancer Hospital & Institute
[2] Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Center of Gastrointestinal Cancer, Peking University Cancer Hospital & Institute
[3] Department of Gastrointestinal Surgery, Peking University Shenzhen Hospital
[4] Department of General Surgery, the First Affiliated Hospital of Nanjing Medical University, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University
关键词
D O I
暂无
中图分类号
R735.2 [胃肿瘤];
学科分类号
100214 ;
摘要
Gastric cancer(GC) is a global health problem, with more than 1 million people newly diagnosed with GC worldwide each year. GC is more prevalent in less developed countries than in more developed countries. About half of all GC cases worldwide occur in East Asia, notably China. Globally, overall incidence rates of GC are declining, which is potentially attributed to a decrease in Helicobacter pylori(H. pylori) infection and the use of refrigeration to preserve foods rather than salt. GC is a multifactorial disease, and its occurrence and development were impacted by environmental and genetic factors. H. pylori infection is the primary risk factor for GC, especially for non-cardia. The prognosis of GC is poor due to stages at the first diagnosis. The 5-year survival rate is less than 10% when patients are diagnosed at an advanced stage, but the rate is as high as 85% if patients are detected at an earlier stage. Endoscopic screening can potentially prevent GC by early diagnosis and early treatment and has been widely adopted in screening programs in East Asian countries, such as Japan and Korea. This review summarizes updated epidemiological aspects, risk factors, and prevention strategies of GC in recent years to help researchers determine the most effective intervention strategies for reducing risk of GC.
引用
收藏
页码:695 / 704
页数:10
相关论文
共 34 条
[1]   Classifying risk level of gastric cancer: Evaluation of questionnaire-based prediction model [J].
Maomao Cao ;
He Li ;
Dianqin Sun ;
Lin Lei ;
Jiansong Ren ;
Jufang Shi ;
Ni Li ;
Ji Peng ;
Wanqing Chen .
Chinese Journal of Cancer Research, 2020, 32 (05) :605-614
[2]   Tumor heterogeneity of gastric cancer: From the perspective of tumor-initiating cell [J].
Jian-Peng Gao ;
Wei Xu ;
Wen-Tao Liu ;
Min Yan ;
Zheng-Gang Zhu .
World Journal of Gastroenterology, 2018, (24) :2567-2581
[3]   Incidence and mortality of stomach cancer in China,2014 [J].
Lei Yang ;
Rongshou Zheng ;
Ning Wang ;
Yannan Yuan ;
Shuo Liu ;
Huichao Li ;
Siwei Zhang ;
Hongmei Zeng ;
Wanqing Chen .
Chinese Journal of Cancer Research, 2018, 30 (03) :291-298
[4]   Evaluating efficacy of screening for upper gastrointestinal cancer in China: a study protocol for a randomized controlled trial [J].
Wanqing Chen ;
Hongmei Zeng ;
Ru Chen ;
Ruyi Xia ;
Zhixun Yang ;
Changfa Xia ;
Rongshou Zheng ;
Wenqiang Wei ;
Guihua Zhuang ;
Xueqin Yu ;
Jie He .
Chinese Journal of Cancer Research, 2017, 29 (04) :294-302
[5]   Helicobacter pylori antibody responses in association with eradication outcome and recurrence: a population-based intervention trial with 7.3-year follow-up in China [J].
Tianyi Wang ;
Yang Zhang ;
Huijuan Su ;
Zhexuan Li ;
Lian Zhang ;
Junling Ma ;
Weidong Liu ;
Tong Zhou ;
Weicheng You ;
Kaifeng Pan .
ChineseJournalofCancerResearch, 2017, 29 (02) :127-136
[6]   Gut microbiome can be restored without adverse events after Helicobacter pylori eradication therapy in teenagers [J].
Gotoda, Takuji ;
Takano, Chika ;
Kusano, Chika ;
Suzuki, Sho ;
Ikehara, Hisatomo ;
Hayakawa, Satoshi ;
Andoh, Akira .
HELICOBACTER, 2018, 23 (06)
[7]  
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J] . Freddie Bray BSc, MSc, PhD,Jacques Ferlay ME,Isabelle Soerjomataram MD, MSc, PhD,Rebecca L. Siegel MPH,Lindsey A. Torre MSPH,Ahmedin Jemal PhD, DVM.CA: A Cancer Journal for Clinicians . 2018 (6)
[8]  
Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study[J] . Eleanor Fewings,Alexey Larionov,James Redman,Mae A Goldgraben,James Scarth,Susan Richardson,Carole Brewer,Rosemarie Davidson,Ian Ellis,D Gareth Evans,Dorothy Halliday,Louise Izatt,Peter Marks,Vivienne McConnell,Louis Verbist,Rebecca Mayes,Graeme R Clark,James Hadfield,Suet-Feung Chin,Manuel R Teixeira,Olivier T Gig
[9]  
Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries[J] . Hongmei Zeng,Wanqing Chen,Rongshou Zheng,Siwei Zhang,John S Ji,Xiaonong Zou,Changfa Xia,Kexin Sun,Zhixun Yang,He Li,Ning Wang,Renqiang Han,Shuzheng Liu,Huizhang Li,Huijuan Mu,Yutong He,Yanjun Xu,Zhentao Fu,Yan Zhou,Jie Jiang,Yanlei Yang,Jianguo Chen,Kuangrong Wei,Dongmei Fan,Jian Wang,Fangxian Fu,Deli Zhao,Guohui Song,Jianshun Chen,Chunxiao Jiang,Xin Zhou,Xiaoping Gu,Feng Jin,Qilong
[10]  
Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries[J] . Claudia Allemani,Tomohiro Matsuda,Veronica Di Carlo,Rhea Harewood,Melissa Matz,Maja Nik?i?,Audrey Bonaventure,Mikhail Valkov,Christopher J Johnson,Jacques Estève,Olufemi J Ogunbiyi,Gulnar Azevedo e Silva,Wan-Qing Chen,Sultan Eser,Gerda Engholm,Charles A Stiller,Alain Monnereau,Ryan R